833 related articles for article (PubMed ID: 17046021)
21. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
[TBL] [Abstract][Full Text] [Related]
22. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens.
Shimomura K; Hardy MA; Oluwole SF
Transplantation; 1995 Oct; 60(8):806-11. PubMed ID: 7482739
[TBL] [Abstract][Full Text] [Related]
23. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.
Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
J Surg Res; 2012 Dec; 178(2):974-81. PubMed ID: 22819314
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous bone marrow and composite tissue transplantation in rats treated with nonmyeloablative conditioning promotes tolerance.
Xu H; Ramsey DM; Wu S; Bozulic LD; Ildstad ST
Transplantation; 2013 Jan; 95(2):301-8. PubMed ID: 23250336
[TBL] [Abstract][Full Text] [Related]
25. Induction of tolerance toward rat cardiac allografts by treatment with allochimeric class I MHC antigen and FTY720.
Chueh SC; Tian L; Wang M; Wang ME; Stepkowski SM; Kahan BD
Transplantation; 1997 Nov; 64(10):1407-14. PubMed ID: 9392303
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
[TBL] [Abstract][Full Text] [Related]
27. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
[TBL] [Abstract][Full Text] [Related]
28. Composite tissue allotransplantation in chimeric hosts part II. A clinically relevant protocol to induce tolerance in a rat model.
Prabhune KA; Gorantla VS; Perez-Abadia G; Francois CG; Vossen M; Laurentin-Perez LA; Breidenbach WC; Wang GG; Anderson GL; Pidwell DJ; Barker JH; Maldonado C
Transplantation; 2003 Dec; 76(11):1548-55. PubMed ID: 14702522
[TBL] [Abstract][Full Text] [Related]
29. Intensity of transplant chronic rejection correlates with level of graft-infiltrating regulatory cells.
Semiletova NV; Shen XD; Baibakov B; Andakyan A
J Heart Lung Transplant; 2010 Mar; 29(3):335-41. PubMed ID: 20080050
[TBL] [Abstract][Full Text] [Related]
30. A partial conditioning approach to achieve mixed chimerism in the rat: depletion of host natural killer cells significantly reduces the amount of total body irradiation required for engraftment.
Neipp M; Gammie JS; Exner BG; Li S; Chambers WH; Pham SM; Ildstad ST
Transplantation; 1999 Aug; 68(3):369-78. PubMed ID: 10459540
[TBL] [Abstract][Full Text] [Related]
31. Long-term observation after simultaneous lung and intra-bone marrow-bone marrow transplantation.
Kaneda H; Adachi Y; Saito Y; Ikebukuro K; Machida H; Suzuki Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Wang J; Imamura H; Ikehara S
J Heart Lung Transplant; 2005 Sep; 24(9):1415-23. PubMed ID: 16143265
[TBL] [Abstract][Full Text] [Related]
32. Prevention of chronic rejection in murine cardiac allografts: a comparison of chimerism- and nonchimerism-inducing costimulation blockade-based tolerance induction regimens.
Shirasugi N; Adams AB; Durham MM; Lukacher AE; Xu H; Rees P; Cowan SR; Williams MA; Pearson TC; Larsen CP
J Immunol; 2002 Sep; 169(5):2677-84. PubMed ID: 12193741
[TBL] [Abstract][Full Text] [Related]
33. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.
Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD
Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174
[TBL] [Abstract][Full Text] [Related]
34. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
35. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance.
Yu S; Nakafusa Y; Flye MW
Surgery; 1994 Aug; 116(2):229-34; discussion 234-5. PubMed ID: 8047989
[TBL] [Abstract][Full Text] [Related]
36. Non-myeloablative conditioning is sufficient to induce mixed chimerism and subsequent acceptance of donor specific cardiac and skin grafts.
Liu C; Zhu P; Saito T; Isaka Y; Nagahara Y; Zhuang J; Li XK
Int Immunopharmacol; 2013 Jul; 16(3):392-8. PubMed ID: 23428909
[TBL] [Abstract][Full Text] [Related]
37. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
[TBL] [Abstract][Full Text] [Related]
38. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
[TBL] [Abstract][Full Text] [Related]
39. A rodent model of in utero chimeric tolerance induction.
Yuh DD; Gandy KL; Hoyt G; Reitz BA; Robbins RC
J Heart Lung Transplant; 1997 Feb; 16(2):222-30. PubMed ID: 9059934
[TBL] [Abstract][Full Text] [Related]
40. Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance.
Hu M; Kramer B; Zhang GY; Wang YM; Watson D; Howden B; McCowage G; Alexander IE; Gunning P; Alexander SI
Transplantation; 2015 Dec; 99(12):2476-84. PubMed ID: 26177088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
